Search research articles
Contact Us
Filters
Showing results (731-740 of 750) with videos related to
Page
of 75
Sort By:
Parkinsonism & Related Disorders
|
January 11, 2025
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data
Tania Nikolcheva, Gennaro Pagano, Nathalie Pross, et al.
NPJ Digital Medicine
|
June 16, 2025
Exploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab
Kirsten I Taylor, Florian Lipsmeier, Marzia A Scelsi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 28, 2018
Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial
Florian Lipsmeier, Kirsten I Taylor, Timothy Kilchenmann, et al.
Autism Research : Official Journal of the International Society for Autism Research
|
September 24, 2017
Adaptive behavior in autism: Minimal clinically important differences on the Vineland-II
C H Chatham, K I Taylor, T Charman, et al.
Nature
|
December 11, 2024
Structure and mechanism of the Zorya anti-phage defence system
Haidai Hu, Philipp F Popp, Thomas C D Hughes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 24, 2020
Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism
Ahmed Al-Qassabi, Tsu-Shuen Tsao, Adriana Racolta, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 4, 2021
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
Thomas Kremer, Kirsten I Taylor, Juliane Siebourg-Polster, et al.
European Urology Focus
|
February 8, 2025
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing Therapies
Drupad Annapureddy, Jacob I Taylor, Ashish M Kamat, et al.
BJU International
|
August 26, 2024
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer
Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell, et al.
Frontiers in Neurology
|
October 18, 2021
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Gennaro Pagano, Frank G Boess, Kirsten I Taylor, et al.
Page
of 75
Search research articles
Search
Showing results (731-740 of 750) with videos related to
Sort By:
Page
of 75
Parkinsonism & Related Disorders
|
January 11, 2025
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data
Tania Nikolcheva, Gennaro Pagano, Nathalie Pross, et al.
NPJ Digital Medicine
|
June 16, 2025
Exploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab
Kirsten I Taylor, Florian Lipsmeier, Marzia A Scelsi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 28, 2018
Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial
Florian Lipsmeier, Kirsten I Taylor, Timothy Kilchenmann, et al.
Autism Research : Official Journal of the International Society for Autism Research
|
September 24, 2017
Adaptive behavior in autism: Minimal clinically important differences on the Vineland-II
C H Chatham, K I Taylor, T Charman, et al.
Nature
|
December 11, 2024
Structure and mechanism of the Zorya anti-phage defence system
Haidai Hu, Philipp F Popp, Thomas C D Hughes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 24, 2020
Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism
Ahmed Al-Qassabi, Tsu-Shuen Tsao, Adriana Racolta, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 4, 2021
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
Thomas Kremer, Kirsten I Taylor, Juliane Siebourg-Polster, et al.
European Urology Focus
|
February 8, 2025
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non-muscle-invasive Bladder Cancer Undergoing Bladder-sparing Therapies
Drupad Annapureddy, Jacob I Taylor, Ashish M Kamat, et al.
BJU International
|
August 26, 2024
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer
Jacob I Taylor, Ashish M Kamat, Michael A O'Donnell, et al.
Frontiers in Neurology
|
October 18, 2021
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Gennaro Pagano, Frank G Boess, Kirsten I Taylor, et al.
Page
of 75